US approves Astrazeneca lung cancer drug Imfinzi for treatment Business Astrazeneca’s lung cancer drug Imfinzi has been approved for treatment in the US to be used both before and after surgery, just days after the company’s market value hit £200bn for the first time. Imfinzi, which is meant to treat early-stage non-small cell lung cancer alongside chemotherapy, is administered before and after surgery. The approval [...]
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial ruling pharma GSK has hit back against a US ruling that found it could be sued over the potential cancer-causing properties of its heartburn drug Zantac.
GSK: Cancer claims plague pharma giant as it settles another Zantac case Pharma GSK has reached another confidential settlement in a Californian lawsuit that had alleged its best-selling indigestion drug, Zantac, was carcinogenic.